Substance use in clinical high risk for psychosis: a review of the literature

Predicting Psychosis

(2012) Paolo Fusar-Poli   ARCHIVES OF GENERAL PSYCHIATRY

Tobacco smoking among people living with a psychotic illness: The second Australian survey of psychosis

(2012) Jae Cooper et al.   AUSTRALIAN AND NEW ZEALAND JOURNAL OF PSYCHIATRY

Cannabis Use in Patients at Clinical High Risk of Psychosis: Impact on Prodromal Symptoms and Transition to Psychosis

(2012) Floor J. van der Meer et al.   CURRENT PHARMACEUTICAL DESIGN

Prospective study of cannabis use in adolescents at clinical high risk for psychosis: impact on conversion to psychosis and functional outcome

(2012) A. M. Auther et al.   PSYCHOLOGICAL MEDICINE

The Psychosis High-Risk State

(2012) Paolo Fusar-Poli et al.   JAMA Psychiatry

Cannabis use and age at onset of symptoms in subjects at clinical high risk for psychosis

(2011) S. Dragt et al.   ACTA PSYCHIATRICA SCANDINAVICA

At Clinical High Risk for Psychosis: Outcome for Nonconverters

(2011) Jean Addington et al.   AMERICAN JOURNAL OF PSYCHIATRY

Methamphetamine Use and Schizophrenia: A Population-Based Cohort Study in California

(2011) Russell C. Callaghan et al.   AMERICAN JOURNAL OF PSYCHIATRY

Substance Use in Adolescence and Psychosis: Clarifying the Relationship

(2010) Emma Barkus et al.   Annual Review of Clinical Psychology

Prediction of Psychosis in Adolescents and Young Adults at High Risk

(2010) Stephan Ruhrmann et al.   ARCHIVES OF GENERAL PSYCHIATRY

Symptomatology and Neuropsychological Functioning in Cannabis Using Subjects at Ultra-High Risk for Developing Psychosis and Healthy Controls

(2010) Nikie Korver et al.   AUSTRALIAN AND NEW ZEALAND JOURNAL OF PSYCHIATRY

The Impact of Cannabis Use on Cognitive Functioning in Patients With Schizophrenia: A Meta-analysis of Existing Findings and New Data in a First-Episode Sample

(2010) M. Yucel et al.   SCHIZOPHRENIA BULLETIN

Predictive validity of clinical variables in the “at risk” for psychosis population: International comparison with results from the North American Prodrome Longitudinal Study

(2010) Andrew Thompson et al.   SCHIZOPHRENIA RESEARCH

Illicit substance use and its correlates in first episode psychosis

(2009) R. Mazzoncini et al.   ACTA PSYCHIATRICA SCANDINAVICA

Anandamide elevation in cerebrospinal fluid in initial prodromal states of psychosis

(2009) Dagmar Koethe et al.   BRITISH JOURNAL OF PSYCHIATRY

Lifetime history of substance misuse in first-episode psychosis: prevalence and its influence on psychopathology and onset of psychotic symptoms

(2009) Moayyad Kamali et al.   Early Intervention in Psychiatry

The endocannabinoid system and the regulation of neural development: potential implications in psychiatric disorders

(2009) Ismael Galve-Roperh et al.   EUROPEAN ARCHIVES OF PSYCHIATRY AND CLINICAL NEUROSCIENCE

The endocannabinoid system as a target for modelling psychosis

(2009) Dagmar Koethe et al.   PSYCHOPHARMACOLOGY

Rates and predictors of remission and recovery during 3 years in 392 never-treated patients with schizophrenia

(2008) M. Lambert et al.   ACTA PSYCHIATRICA SCANDINAVICA

Prediction of Psychosis in Youth at High Clinical Risk

(2008) Tyrone D. Cannon et al.   ARCHIVES OF GENERAL PSYCHIATRY

Das Basel Screening Instrument für Psychosen (BSIP): Entwicklung, Aufbau, Reliabilität und Validität

(2008) A. Riecher-Rössler et al.   FORTSCHRITTE DER NEUROLOGIE PSYCHIATRIE

A Review of Second-Generation Antipsychotic Discontinuation in First-Episode Psychosis

(2008) BRIAN J. MILLER   Journal of Psychiatric Practice

Factors influencing relapse during a 2-year follow-up of first-episode psychosis in a specialized early intervention service

(2008) A. Malla et al.   PSYCHOLOGICAL MEDICINE

Temporal association of cannabis use with symptoms in individuals at clinical high risk for psychosis

(2008) C CORCORAN et al.   SCHIZOPHRENIA RESEARCH